Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(1.71)
# 3,425
Out of 4,818 analysts
85
Total ratings
22.62%
Success rate
-9.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.69 | +197.40% | 2 | Apr 16, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $7.46 | +382.57% | 14 | Apr 3, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $20.73 | +261.79% | 12 | Mar 31, 2025 | |
| MURA Mural Oncology | Maintains: Buy | $18 → $6 | $2.77 | +116.61% | 5 | Mar 26, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.43 | +319.58% | 9 | Mar 21, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $75 → $50 | $7.34 | +581.20% | 1 | Mar 12, 2025 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $0.85 | +1,658.91% | 16 | Mar 12, 2025 | |
| ENGN enGene Holdings | Reiterates: Buy | $25 | $3.91 | +539.39% | 2 | Mar 11, 2025 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $40 → $50 | $32.60 | +53.37% | 13 | Nov 26, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $4 | $1.21 | +230.58% | 11 | Nov 11, 2024 |
ImmunityBio
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $2.69
Upside: +197.40%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $7.46
Upside: +382.57%
CG Oncology
Mar 31, 2025
Reiterates: Buy
Price Target: $75
Current: $20.73
Upside: +261.79%
Mural Oncology
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.77
Upside: +116.61%
Erasca
Mar 21, 2025
Reiterates: Buy
Price Target: $6
Current: $1.43
Upside: +319.58%
Corbus Pharmaceuticals Holdings
Mar 12, 2025
Reiterates: Buy
Price Target: $75 → $50
Current: $7.34
Upside: +581.20%
Werewolf Therapeutics
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.85
Upside: +1,658.91%
enGene Holdings
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $3.91
Upside: +539.39%
Scholar Rock Holding
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $32.60
Upside: +53.37%
Ikena Oncology
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.21
Upside: +230.58%